- Home
- Publications
- Publication Search
- Publication Details
Title
Pancreatic Cancer Heterogeneity Can Be Explained Beyond the Genome
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-04-05
DOI
10.3389/fonc.2019.00246
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Amphipathic helical peptides hamper protein-protein interactions of the intrinsically disordered chromatin nuclear protein 1 (NUPR1)
- (2018) Patricia Santofimia-Castaño et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models
- (2018) Susan Tsai et al. BMC CANCER
- Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study
- (2018) Antoine Italiano et al. LANCET ONCOLOGY
- A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent
- (2018) Manjusha Thakar et al. PLoS One
- Epigenetic reprogramming using 5-azacytidine promotes an anti-cancer response in pancreatic adenocarcinoma cells
- (2018) Luc Gailhouste et al. Cell Death & Disease
- Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes
- (2018) Gwen Lomberk et al. Nature Communications
- Organoid profiling identifies common responders to chemotherapy in pancreatic cancer
- (2018) Hervé Tiriac et al. Cancer Discovery
- Depletion of HDAC1, 7 and 8 by Histone Deacetylase Inhibition Confers Elimination of Pancreatic Cancer Stem Cells in Combination with Gemcitabine
- (2018) Mao-Hua Cai et al. Scientific Reports
- Cancer epigenetics: Moving forward
- (2018) Angela Nebbioso et al. PLoS Genetics
- Development of a Method to Implement Whole-Genome Bisulfite Sequencing of cfDNA from Cancer Patients and a Mouse Tumor Model
- (2018) Elaine C. Maggi et al. Frontiers in Genetics
- Role of Gene Therapy in Pancreatic Cancer—A Review
- (2018) Mizuho Sato-Dahlman et al. Cancers
- Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)
- (2017) Masaru Katoh INTERNATIONAL JOURNAL OF ONCOLOGY
- Combined AURKA and H3K9 Methyltransferase Targeting Inhibits Cell Growth By Inducing Mitotic Catastrophe
- (2017) Angela Mathison et al. MOLECULAR CANCER RESEARCH
- SWI/SNF complex in cancer
- (2017) Chao Lu et al. NATURE GENETICS
- Intrinsically disordered chromatin protein NUPR1 binds to the C-terminal region of Polycomb RING1B
- (2017) Patricia Santofimia-Castaño et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts
- (2017) Rémy Nicolle et al. Cell Reports
- Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells
- (2017) Anup Sharma et al. PLoS One
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- DNMT1 Inhibition Reprograms Pancreatic Cancer Stem Cells via Upregulation of the miR-17-92 Cluster
- (2016) S. Zagorac et al. CANCER RESEARCH
- GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer
- (2016) Paola Martinelli et al. GUT
- Restitution of Tumor Suppressor MicroRNA-145 Using Magnetic Nanoformulation for Pancreatic Cancer Therapy
- (2016) Saini Setua et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Safety and efficacy of ezetimibe: A meta-analysis
- (2015) Gianluigi Savarese et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- First-in-man Phase 1 Clinical Trial of Gene Therapy for Advanced Pancreatic Cancer: Safety, Biodistribution, and Preliminary Clinical Findings
- (2015) Louis Buscail et al. MOLECULAR THERAPY
- Whole genomes redefine the mutational landscape of pancreatic cancer
- (2015) Nicola Waddell et al. NATURE
- Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
- (2015) Richard A Moffitt et al. NATURE GENETICS
- Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma
- (2015) Pawel K Mazur et al. NATURE MEDICINE
- The selection and function of cell type-specific enhancers
- (2015) Sven Heinz et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models
- (2015) P L Garcia et al. ONCOGENE
- Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma
- (2015) Fabienne Guillaumond et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer
- (2015) Yue Zhao et al. Targeted Oncology
- Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
- (2015) Agnieszka K. Witkiewicz et al. Nature Communications
- Association between cholesterol intake and pancreatic cancer risk: Evidence from a meta-analysis
- (2015) Hongqiang Chen et al. Scientific Reports
- Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer
- (2015) Monika Bauden et al. Clinical Epigenetics
- A subgroup of pancreatic adenocarcinoma is sensitive to the 5-aza-dC DNA methyltransferase inhibitor
- (2015) Odile Gayet et al. Oncotarget
- A microRNA meta-signature for pancreatic ductal adenocarcinoma
- (2014) Adam E Frampton et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling
- (2014) Katia Nones et al. INTERNATIONAL JOURNAL OF CANCER
- Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer
- (2014) MAKOTO ABUE et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Liquid Biopsies: Genotyping Circulating Tumor DNA
- (2014) Luis A. Diaz et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel Methylation Biomarker Panel for the Early Detection of Pancreatic Cancer
- (2013) J. M. Yi et al. CLINICAL CANCER RESEARCH
- Non-coding RNAs as direct and indirect modulators of epigenetic regulation
- (2013) Veronica J Peschansky et al. Epigenetics
- Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression
- (2013) Jun Gao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Abstract LB-214: Interim results from a randomized Phase 1-2 first-in-human (FIH) study of PK/PD guided escalating doses of SGI-110, a novel subcutaneous (SQ) second generation hypomethylating agent (HMA) in relapsed/refractory MDS and AML
- (2012) Jean Pierre Issa et al. CANCER RESEARCH
- Epigenetic Resensitization to Platinum in Ovarian Cancer
- (2012) D. Matei et al. CANCER RESEARCH
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Restitution of Tumor Suppressor MicroRNAs Using a Systemic Nanovector Inhibits Pancreatic Cancer Growth in Mice
- (2011) D. Pramanik et al. MOLECULAR CANCER THERAPEUTICS
- Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
- (2011) Eric A Collisson et al. NATURE MEDICINE
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequent genomic copy number gain and overexpression of GATA-6 in pancreatic carcinoma
- (2010) Baojin Fu et al. CANCER BIOLOGY & THERAPY
- The Silencing of MicroRNA 148a Production by DNA Hypermethylation Is an Early Event in Pancreatic Carcinogenesis
- (2010) N. Hanoun et al. CLINICAL CHEMISTRY
- Epigenetic therapies for chemoresensitization of epithelial ovarian cancer
- (2009) Daniela E. Matei et al. GYNECOLOGIC ONCOLOGY
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- Methylation profile of circulating plasma DNA in patients with pancreatic cancer
- (2008) Anatoliy A. Melnikov et al. JOURNAL OF SURGICAL ONCOLOGY
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now